Alphabet — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Spero Therapeutics is a clinical-stage biopharmaceutical company developing medicines for immune-mediated diseases, led by SP001, a third-generation anti-CD40L antibody targeting IgG4-related disease.
BiotechCambridge, US
Ankit Mahadevia(Executive Officer, Director)Stephen Garbacz(Executive Officer)
BoardJean-Francois Formela(Director)inReza Halse(Director)Casper Breum(Director)Vikas Goyal(Director)
Co-investorsHEALTHCARE ROYALTY PARTNERSMRL Ventures FundOUP (Osage University Partners)RA CapitalAtlas Venture
Safe Superintelligence Inc. develops AI systems focused on building safe superintelligence through aligned research and engineering.
AI & Machine LearningDeep TechPalo Alto, US
Ilya Sutskever(Co-founder & CEO)inDaniel Levy(Founder)
Co-investorsAndreessen HorowitzSequoia CapitalDST GlobalGreenoaksLightspeed Venture PartnersNVIDIA
Waymo develops autonomous ride-hailing and delivery services using self-driving vehicle technology.
AI & Machine LearningMobility & TransportationRoboticsSan Francisco, US
Tekedra Mawakana(Co-Chief Executive Officer)inDmitri Dolgov(Co-Chief Executive Officer)
Co-investorsAndreessen HorowitzBessemer Venture PartnersCapitalGKleiner PerkinsOperator CollectivePrime Ventures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.